Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 4 January 1980:
Vol. 207. no. 4426, pp. 68 - 71
DOI: 10.1126/science.6965328
Prev | Table of Contents | Next

Articles

Science, Vol 207, Issue 4426, 68-71
Copyright © 1980 by American Association for the Advancement of Science

articles

Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen

ID Bernstein, MR Tam, and RC Nowinski

Monoclonal antibodies against a thymus cell differentiation antigen (Thy-1.1) were effective in the therapy of a transplanted mouse leukemia. Passive immunization resulted in high titers of cytotoxic antibody in the serum of treated mice and the suppression of metastatic tumor cells. The tumor-suppressive effects of the monoclonal antibodies were amplified by the administration of exogenous complement. This combined antibody and complement therapy resulted in the cure of leukemia in a significant proportion of the treated animals.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
CD25+CD4+ Regulatory T Cells and Memory T Cells Prevent Lymphopenia-Induced Proliferation of Naive T Cells in Transient States of Lymphopenia.
C. Bourgeois and B. Stockinger (2006)
J. Immunol. 177, 4558-4566
   Abstract »    Full Text »    PDF »
Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions.
B. R. Blazar, C. J. Lees, P. J. Martin, R. J. Noelle, B. Kwon, W. Murphy, and P. A. Taylor (2000)
J. Immunol. 165, 4901-4909
   Abstract »    Full Text »    PDF »
Transplantation of leukemic bone marrow treated with cytotoxic antileukemic antibodies and complement.
M. Trigg and D. Poplack (1982)
Science 217, 259-261
   Abstract »    PDF »
A conjugate of alpha-amanitin and monoclonal immunoglobulin G to Thy 1.2 antigen is selectively toxic to T lymphoma cells.
M. Davis and J. Preston 3rd (1981)
Science 213, 1385-1388
   Abstract »    PDF »
Immunology.
R. A. Good (1981)
JAMA 245, 2197-2198
   Abstract »    PDF »
Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo.
W. Young Jr and S. Hakomori (1981)
Science 211, 487-489
   Abstract »    PDF »
Human monoclonal antibody against Forssman antigen.
R Nowinski, C Berglund, J Lane, M Lostrom, I Bernstein, W Young, S. Hakomori, L Hill, and M Cooney (1980)
Science 210, 537-539
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)